Items tagged with Treatment
TB CAB Statement (post with simple image)
TB CAB Access Considerations Statement Regarding Johnson & Johnson Announcement of Bedaquiline Price Reduction
Landmark TB trial identifies shorter-course treatment regimen (post with simple image)
Landmark phase III trial shows that the shorter regimen containing rifapentine and moxifloxacin can safely and effectively cure TB in four months.
SHINE trial on shorter treatment for children with minimal TB (post with simple image)
TB treatment can be shortened from six to four months in 80% of children.
First digital adherence technology in the GDF’s product catalog (post with simple image)
Smart medication container included in Stop TB Partnership's Global Drug Facility (GDF) product catalog.
TAG's 2020 Pipeline Report: TB chapters released (post with simple image)
Treatment Action Group (TAG) launches newly available TB chapters of its 2020 Pipeline Report.
Landmark TB trials results published in New England Journal of Medicine (post with simple image)
A shorter regimen containing rifapentine and moxifloxacin can cure TB in four months.
Advocates ring the alarm on TB medicines and diagnostics stock outs across India (post with simple image)
Civil society networks in India call for the Ministry of Health and Family Welfare and the National TB Elimination Program to take urgent action.
International support for compulsory license to address access barriers to life-saving TB medicines (post with simple image)
Advocates urge the Indian government to issue compulsory licenses for patents on bedaquiline and delamanid to make the drugs more affordable and accessible.
TAGline: Delivering on the promise of long-acting formulations (post with simple image)
October 2021 issue of TAGline delves deep into the development of long-acting formulations for the treatment and prevention of HIV, TB, hepatitis C, and malaria.
An Activist’s Guide to Shorter Treatment for Drug-Sensitive TB (post with simple image)
This new resource provides activists with information about two shorter treatment regimens for drug-sensitive TB, and equips them with actions they can take and arguments they can use to advocate for access to those regimens.
Page 103 of 108 · Total posts: 0
←First 102 103 104 Last→